IL103111A - Cyclic nitrones a process for their production and pharmaceutical compositions containing them - Google Patents

Cyclic nitrones a process for their production and pharmaceutical compositions containing them

Info

Publication number
IL103111A
IL103111A IL10311192A IL10311192A IL103111A IL 103111 A IL103111 A IL 103111A IL 10311192 A IL10311192 A IL 10311192A IL 10311192 A IL10311192 A IL 10311192A IL 103111 A IL103111 A IL 103111A
Authority
IL
Israel
Prior art keywords
compound according
pharmaceutical composition
compounds
reaction
mmol
Prior art date
Application number
IL10311192A
Other languages
English (en)
Other versions
IL103111A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL103111A0 publication Critical patent/IL103111A0/xx
Publication of IL103111A publication Critical patent/IL103111A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL10311192A 1991-09-12 1992-09-08 Cyclic nitrones a process for their production and pharmaceutical compositions containing them IL103111A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75806391A 1991-09-12 1991-09-12
US82807592A 1992-01-30 1992-01-30

Publications (2)

Publication Number Publication Date
IL103111A0 IL103111A0 (en) 1993-02-21
IL103111A true IL103111A (en) 1996-07-23

Family

ID=27116485

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10311192A IL103111A (en) 1991-09-12 1992-09-08 Cyclic nitrones a process for their production and pharmaceutical compositions containing them

Country Status (18)

Country Link
EP (1) EP0532027B1 (cs)
JP (1) JP3255989B2 (cs)
KR (1) KR100232025B1 (cs)
AR (1) AR247731A1 (cs)
AT (1) ATE194599T1 (cs)
AU (1) AU652662B2 (cs)
DE (1) DE69231238T2 (cs)
DK (1) DK0532027T3 (cs)
ES (1) ES2149161T3 (cs)
FI (1) FI101071B (cs)
GR (1) GR3034551T3 (cs)
HU (1) HU216788B (cs)
IL (1) IL103111A (cs)
MX (1) MX9205199A (cs)
NO (1) NO179514C (cs)
NZ (1) NZ244268A (cs)
PT (1) PT532027E (cs)
TW (1) TW257755B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0863878T1 (en) * 1995-09-11 2003-04-30 Aventis Pharmaceuticals, Inc. Cyclic nitrones and pharmaceutical compositions containing them
PT1288203E (pt) * 1995-09-11 2005-08-31 Aventis Pharma Inc Nitronas ciclicas e composicoes farmaceuticas que as contem
DE10303254B3 (de) * 2003-01-28 2004-09-23 Johannes-Gutenberg-Universität Mainz 3,3-Dimethyl-8-oxoisochinoline, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und deren Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3044930A (en) * 1960-12-08 1962-07-17 Phillips Petroleum Co N-oxides of heterocyclic nitrogen compounds as bird and rodent repellents
AU653921B2 (en) * 1989-10-17 1994-10-20 Oklahoma Medical Research Foundation Method and compositions for inhibition of disorders associated with oxidative damage

Also Published As

Publication number Publication date
FI101071B (fi) 1998-04-15
NO179514C (no) 1996-10-23
PT532027E (pt) 2000-10-31
MX9205199A (es) 1994-01-31
AR247731A1 (es) 1995-03-31
ATE194599T1 (de) 2000-07-15
KR930005981A (ko) 1993-04-20
JP3255989B2 (ja) 2002-02-12
IL103111A0 (en) 1993-02-21
ES2149161T3 (es) 2000-11-01
FI924076L (fi) 1993-03-13
EP0532027A1 (en) 1993-03-17
NO923538L (no) 1993-03-15
DE69231238D1 (de) 2000-08-17
FI924076A0 (fi) 1992-09-11
NO923538D0 (no) 1992-09-11
EP0532027B1 (en) 2000-07-12
TW257755B (cs) 1995-09-21
HUT67022A (en) 1995-01-30
AU652662B2 (en) 1994-09-01
DK0532027T3 (da) 2000-10-23
AU2280092A (en) 1993-03-18
HU9202923D0 (en) 1992-11-30
GR3034551T3 (en) 2001-01-31
NO179514B (no) 1996-07-15
DE69231238T2 (de) 2000-12-21
KR100232025B1 (ko) 1999-12-01
JPH05213870A (ja) 1993-08-24
NZ244268A (en) 1994-09-27
HU216788B (hu) 1999-08-30

Similar Documents

Publication Publication Date Title
US5677315A (en) Cyclic nitrones
TWI507410B (zh) 新穎磷酸二酯酶抑制劑
JP6162820B2 (ja) 炭素環式および複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
JP3708957B2 (ja) （−）−エゼロリン、（−）−ｎ１−ノルエゼロリンおよび（−）−ｎ１−ベンジルノルエゼロリンの置換フェンゼリンおよびフェニルカルバミン酸塩：特異的アセチルコリンエステラーゼ阻害薬としての使用
WO2021139741A1 (zh) 大麻二酚衍生物及其制备方法和在医药上的应用
KR100225927B1 (ko) 콜린에스테라제 저해제로서의 제네세린 유도체
KR20090126252A (ko) 신규한 포스포디에스테라제 억제제
JP2022505143A (ja) 新規化合物
JP3064411B2 (ja) インデノインドール化合物▲ｉｉ▼
JP2016507580A (ja) 置換フェニルヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
AU652662B2 (en) Cyclic nitrones
KR20140105598A (ko) [1,2,4]트리아졸로피리딘 및 포스포디에스테라제 억제제로서의 이의 용도
EP0863878B1 (en) Cyclic nitrones and pharmaceutical compositions containing them
KR100856141B1 (ko) 모노아민 산화효소 ｂ 저해제로서의 벤즈아제핀 유도체
AU659486B2 (en) Novel alpha-mannosidase inhibitors
EP0323325B1 (fr) Dérivés tricycliques agonistes des récepteurs cholinergiques, procédé pour leur préparation et médicaments en contenant
EP0097636A1 (fr) Nouveaux dérivés d'indolizine, leur procédé de préparation ainsi que les compositions thérapeutiques les contenant
JP2894617B2 (ja) ２―フエニルインドール誘導体
FR2641536A1 (fr) Derives d'alcanoyloxy-3 ((n-(aryl-2 oxo-2 ethyl) methylamino)-2 ethyl)-5 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
JPH0352888A (ja) 新規化合物、その製法及びそれを含む医薬組成物
UA79666C2 (en) 1,2,4-triaminobenzene derivatives suitable for the treatment of the central nervous system disorders
BE819146A (fr) Nouveaux derives pyrimidiniques et leur procede de preparation
BE708668A (cs)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PARMACEUTICALS, INC.

KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees